Showing 1301-1310 of 1395 results for "".
- Horizon Therapeutics to Acquire Viela Bio to Grow Rare Disease Medicine Portfoliohttps://modernod.com/news/horizon-therapeutics-to-acquire-viela-bio-to-grow-rare-disease-medicine-portfolio/2478819/Horizon Therapeutics and Viela Bio announced the companies have entered into a definitive agreement under which Horizon will acquire all of the issued and outstanding shares of Viela Bio common stock for $53 per share in cash, which represents a fully diluted equity value of approximately $3.05 b
- Zenni Releases New Anti-Fog Glasses Lenses to Address Mask-Related Fogginghttps://modernod.com/news/zenni-releases-new-anti-fog-glasses-lenses-to-address-mask-related-fogging/2478797/Zenni announced a 2-in-1 anti-fog + anti-reflective lens solution to solve a pain point for glasses wearers during the pandemic. Developed in 2020 as a response to the pervasive consumer issue of glasses fogging up while wearing face coverings, these new anti-fog coated lenses are the only low pr
- More Adults with Vision Loss Seeking Help Staying Connected During Pandemichttps://modernod.com/news/more-adults-with-vision-loss-seeking-help-staying-connected-during-pandemic/2478772/Since the onset of COVID-19 those with visual impairments have faced disproportionate vulnerabilities from living in extended isolation. Newly released data has shown that clinical depression within the visually impaired community is being reported at nearly three times the level than the general
- GenSight Biologics Announces Publication of Results from Lumevoq RESCUE Phase 3 Trialhttps://modernod.com/news/gensight-biologics-announces-publication-of-results-from-lumevoq-rescue-phase-3-trial/2478755/GenSight Biologics announced that Ophthalmology has published results from the RESCUE pivotal phase 3 clinical trial of Lumevoq gene therapy in ND4 Leber Hereditary Optic Neuropathy (LHON) subjects. The paper, published in the January issue under the title, “Efficacy and safety
- CorNeat Vision’s First Patient Regains Sight Following Artificial Cornea Implantation at Rabin Medical Centerhttps://modernod.com/news/corneat-visions-first-patient-regains-sight-following-artificial-cornea-implantation-at-rabin-medical-center/2478741/The CorNeat KPro, an artificial cornea that integrates with the eye wall with no reliance on donor tissue, was successfully implanted in a human. The surgery was performed on a bilaterally blind, 78-year-old male at Rabin Medical Center, Israel, by Professor
- Study: Hospitals At or Near Full COVID-19 ICU Capacity Increase by 90% Over Past Few Monthshttps://modernod.com/news/study-hospitals-at-or-near-full-covid-19-icu-capacity-increase-by-90-over-past-few-months/2478722/A new study found a 90% increase in hospitals reaching intensive care unit (ICU) capacity from July through December, with rural hospitals facing the biggest capacity issues, according to a FierceHealthcare
- FDA Panel Endorses Moderna’s COVID-19 Vaccine for Emergency Usehttps://modernod.com/news/fda-panel-endorses-modernas-covid-19-vaccine-for-emergency-use/2478678/An FDA advisory panel on Thursday voted 20-0, with one abstention, that the benefits of Moderna’s COVID-19 vaccine mRNA-1273 outweigh its risks in people 18 years and older. The panel backing sets the stage for the FDA to issue an emergency-use authorization (EUA) for the candidate, which i
- MHRA Advises Against Use of Pfizer, BioNTech’s COVID-19 Vaccine in Those With “Significant History” of Allergic Reactionshttps://modernod.com/news/mhra-advises-against-use-of-pfizer-biontechs-covid-19-vaccine-in-those-with-significant-history-of-allergic-reactions/2478646/The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) on Wednesday warned that people who have a “significant history” of allergic reactions should not receive Pfizer and BioNTech’s COVID-19 vaccine BNT162b2. The regulator issued the alert because two NHS wor
- Registration Open for International Sports Vision Association 2021 Virtual Annual Conferencehttps://modernod.com/news/registration-open-for-international-sports-vision-association-2021-virtual-annual-conference/2478628/Registration is now open for “Joining Forces to Enhance Athletic Performance,” (www.isva2021.com) the 5th Annual International Sports Vision Association (ISVA) conference. The 2021 conference will be live online on February 20-21, 2021.
- FDA Authorizes Regeneron’s Dual COVID-19 Antibody Treatment for Emergency Usehttps://modernod.com/news/fda-authorizes-regenerons-dual-covid-19-antibody-treatment-for-emergency-use/2478587/The FDA has issued an emergency-use authorization (EUA) to Regeneron’s filing for casirivimab and imdevimab to be administered together to treat mild-to-moderate COVID-19 in adults and paediatric patients. The monoclonal antibodies, also referred to as REGN-COV2 or as REGEN-COV2 when used i